SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-15-108190
Filing Date
2015-03-27
Accepted
2015-03-27 09:24:52
Documents
7
Effectiveness Date
2015-03-27

Document Format Files

Seq Description Document Type Size
1 DEFA14A d893996ddefa14a.htm DEFA14A 45310
2 GRAPHIC g893996notice_pg01a.jpg GRAPHIC 6161
3 GRAPHIC g893996notice_pg01b.jpg GRAPHIC 2452
4 GRAPHIC g893996notice_pg02.jpg GRAPHIC 2451
5 GRAPHIC g893996notice_pg03.jpg GRAPHIC 2459
6 GRAPHIC g893996notice_pg04.jpg GRAPHIC 2454
7 GRAPHIC g893996notice_xxx.jpg GRAPHIC 3213
  Complete submission text file 0001193125-15-108190.txt   73731
Mailing Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Filer) CIK: 0001274792 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35409 | Film No.: 15729208
SIC: 2834 Pharmaceutical Preparations